<DOC>
	<DOCNO>NCT01100125</DOCNO>
	<brief_summary>It well establish inhibition dipeptidyl peptidase ( DPP ) -IV reduces glucose level preserve pancreatic beta cell function patient type 2 diabetes . DPP-IV inhibitor stimulate insulin secretion well insulin biosynthesis inhibit glucagon secretion pancreas increase incretin ( GLP-1 ) level . Recent study report combination therapy DPP-IV inhibitor oral antidiabetic medication additive synergistic effect lower glycose level , preserve beta-cell mass function well enhance insulin sensitivity . However , study glucose lower effect DPP-IV inhibitor patient type 2 diabetes insulin treatment . The researcher hypothesize DPP-IV inhibitor add-on therapy insulin treatment may favorable effect glucose control endogenous insulin secretory function type 2 diabetic patient . The researcher plan compare sitagliptin ( DPP-IV inhibitor ) add-on therapy insulin dose increase therapy uncontrolled type 2 diabetes insulin treatment .</brief_summary>
	<brief_title>Sitagliptin Versus Insulin Dose Increase Type 2 Diabetes Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Type 2 diabetes HbA1c ≥ 7 % Age ≥ 18 Insulin treatment without oral antidiabetic medication Contraindication sitagliptin Pregnant breast feed woman Type 1 diabetes , gestational diabetes , diabetes secondary cause Chronic hepatitis B C ( except healthy carrier HBV ) , liver disease ( AST/ALT &gt; 3fold upper limit normal ) Renal failure ( Cr &gt; 2.0 ) Cancer within 5 year Not appropriate oral antidiabetic agent Medication affect glycemic control Disease affect efficacy safety drug Other clinical trial within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Sitagliptin</keyword>
	<keyword>insulin</keyword>
	<keyword>C-peptide</keyword>
</DOC>